| Net Cash Provided by (Used in) Operating Activities |
-55.7M |
USD |
-213% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
58.9M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
82.7M |
shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
45.1M |
USD |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
43.5M |
USD |
+35.1% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
15.2M |
USD |
-6.1% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
157K |
USD |
|
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
Q3 2023 |
| Additional Paid in Capital |
808M |
USD |
+15.7% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
60.5M |
USD |
-3.66% |
Q2 2025 |
Q2 2025 |